Skip to content
★ Sign in to follow
FC

Frank Condella Jr.

Executive
Juniper Pharmaceuticals Inc
Total declarations
16
Company
1
▲ Purchases (7 ops.)
€358k
▼ Sales (0 ops.)
—

Latest filing published 03 Aug 2016 for JUNIPER PHARMACEUTICALS INC.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Frank Condella Jr.: trading record in brief

Frank Condella Jr. discloses dealings in Juniper Pharmaceuticals Inc to SEC (Form 4). The record holds 16 filings, for trades running from 21 May 2009 to 2 August 2016.

Purchases make up the whole of the open-market record (7 purchases, €358k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 1 option exercise.

In size, the median ticket on the buying side is €48k.

The record was last updated on 3 August 2016 with a share grant in Juniper Pharmaceuticals Inc. The most recent open-market purchase was published on 19 November 2015, 4,008 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Frank Condella Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations